Financial News

Galderma Delivers Record Net Sales of $3.2 Billion in the First Nine Months of 2024

Dermatological skincare net sales were $990 million, growing by 10.6% year-on-year at a constant currency basis, with Cetaphil and Alastin the key drivers.

Author Image

By: Lianna Albrizio

Associate Editor

Galderma Group AG recorded net sales of $3.2 billion in the first nine months of 2024, a 9.2% year-on-year increase in constant currency, predominantly driven by volume growth complemented by favorable mix. The company also reported it achieved the highest third quarter net sales in its history, achieving constant currency year-on-year growth of 10.6% for dermatological skincare, and 2.9% for therapeutic dermatology for the first nine months of 2024. “By executing on our unique integrated ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters